The Cancer Immunotherapy Consortium (CIC) contributes to the creation of white papers, response documents, and peer-reviewed publications advancing novel outcomes from workshops that seek practical solutions to today's challenges in cancer immunotherapy development.
Publications prior to 2010 are credited to the Cancer Vaccine Consortium, the former name of the Cancer Immunotherapy Consortium.
A browser plugin may be required for the PDF file found this page.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
For Liver Cancer Awareness Month, we round up the latest news and research from the people changing the future of liver cancer treatment.
At CRI's 33rd Annual Awards Dinner, philanthropic family legacies and scientific advances in cancer immunology received recognition and honor while raising funds for cancer research.